Skip to content

Left vs Right Radial Approach in the Setting of Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02239757
Enrollment
200
Registered
2014-09-15
Start date
2013-01-31
Completion date
2015-01-31
Last updated
2015-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transradial Approach, Primary PCI, ST-segment Elevation Myocardial Infarction

Keywords

Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction

Brief summary

Outcomes of patients with acute ST-elevation myocardial infarction (STEMI) are directly related to reperfusion time. Effect of transradial approach (left vs right) on reperfusion time has not been fully studied for SETMI patients undergoing primary percutaneous coronary intervention (PCI). The aim of this study was to randomly investigate the efficacy and safety of left radial approach for primary PCI in STEMI patients compared with right radial approach.

Detailed description

The investigators will enroll consecutively for 3 years all STEMI patients undergoing primary PCI. Patients will be included within 12 hours of symptom onset for primary PCI. Patients will be excluded if they are in cardiogenic shock.

Interventions

Primary PCI performed through left radial approach.

Primary PCI performed through right radial approach.

Sponsors

Capital Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

All consecutive patients with ST-segment elevation myocardial infarction within 12 hours of symptom onset for primary PCI.

Exclusion criteria

Patients are excluded if they were in cardiogenic shock.

Design outcomes

Primary

MeasureTime frame
Needle to balloon time1 day

Secondary

MeasureTime frameDescription
Radiation dose7 daysRadiation dose include cumulative air kerma (CAK) and CAK dose area product (CAK DAP)
Fluoroscopy time7 days
Contrast volume7 days

Other

MeasureTime frameDescription
Vascular complications7 daysVascular complications include pseudoaneurysm, arteriovenous fistula, lose of radial artery pulse, puncture site bleeding and forearm hematoma.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026